Changhai Hospital: Prostatic Neoplasms trials
The registry lists 10 Prostatic Neoplasms studies with Changhai Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.
Phase 1 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate CancerEnrolling by invitationNCT07583160Phase 1
- Adjuvant Hypofractionated Radiotherapy for Prostate CancerRecruitingNCT06335693Not applicable
- Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate CancerRecruitingNCT06325995Not applicable
- Radical Hypofractionated Radiotherapy for Localized Prostate CancerRecruitingNCT06325774Not applicable
- Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate CancerNot yet recruitingNCT06198387Not applicable
- Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate CancerNot yet recruitingNCT05707468Not applicable
- Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate CancerRecruitingNCT04599686Not applicable
- Integrated Boost to the Dominant Intraprostatic Nodule Based on Ga-68 PSMA PET/MR Study of SBRT With Prostate CancerStatus unknownNCT04599699Not applicable
- An RCT to Compare Early Continence Recovery After RARP With or Without Sustainable Functional Urethral ReconstructionCompletedNCT04037800Not applicable
- Learning Curve of Digital Rectal Examination for Prostate Cancer Among InternshipStatus unknownNCT03479359